<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Roseola infantum (exanthem subitum)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Roseola infantum (exanthem subitum)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Roseola infantum (exanthem subitum)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cécile Tremblay, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael T Brady, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Roseola infantum (also known as exanthem subitum, sixth disease, pseudorubella, exanthem criticum, and three-day fever) is caused by the B variant of human herpesvirus 6 (HHV-6). It is a clinical syndrome characterized by three to five days of high fever (may exceed 40°C [104°F]) that resolves abruptly and is followed by development of a rash (<a class="graphic graphic_picture graphicRef81967" href="/z/d/graphic/81967.html" rel="external">picture 1</a>).</p><p>The clinical manifestations, diagnosis, and treatment of roseola infantum will be reviewed here. The virology, pathogenesis, epidemiology, and other clinical manifestations of HHV-6 in children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8302.html" rel="external">"Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection"</a> and  <a class="medical medical_review" href="/z/d/html/5969.html" rel="external">"Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Human herpesvirus 6B (HHV-6B) is the most frequent cause of roseola [<a href="#rid1">1,2</a>]. Other causes include HHV-7, enteroviruses (coxsackieviruses A and B, echoviruses), adenoviruses, and parainfluenza virus type 1 [<a href="#rid1">1,3,4</a>].</p><p class="headingAnchor" id="H3370942457"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H975650823"><span class="h2">Prevalence and seasonality</span><span class="headingEndMark"> — </span>Roseola is an illness of young children, with a peak prevalence between 7 and 13 months [<a href="#rid5">5</a>]. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in males and females [<a href="#rid1">1,6</a>].</p><p>It occurs throughout the year, but the peak incidence is in the spring and fall seasons [<a href="#rid1">1,5</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Most cases of roseola occur sporadically, without known exposure [<a href="#rid1">1,5,7</a>]. However, secondary cases and horizontal transmission have been reported [<a href="#rid1">1,8,9</a>]. Asymptomatic shedding of human herpesvirus 6 (HHV-6) variant B respiratory droplets by older siblings and parents has been responsible for transmission to young infants. Transmission from household rather than community contacts is supported by studies from Japan and Turkey demonstrating that the incidence of roseola did not change during the coronavirus disease 2019 pandemic, in contrast to the incidence of other common respiratory infections (eg, influenza, respiratory syncytial virus) [<a href="#rid10">10-13</a>].</p><p>The modes of transmission, duration of shedding, and incubation periods vary depending upon the etiologic agent [<a href="#rid3">3</a>]. HHV-6 most likely is transmitted by asymptomatic shedding of virus in secretions of close contacts [<a href="#rid5">5,14,15</a>]. The duration of shedding for HHV-6 is not known but is thought to be lifelong, with an increase in viral shedding in the convalescent phase [<a href="#rid14">14,16</a>]. The mean incubation period for HHV-6B is 9 to 10 days [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/z/d/html/8302.html" rel="external">"Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection", section on 'Incubation period and transmission'</a>.)</p><p>Transmission of less common causes of roseola is discussed separately:</p><p class="bulletIndent1">Human herpesvirus 7 (see  <a class="medical medical_review" href="/z/d/html/8309.html" rel="external">"Human herpesvirus 7 infection", section on 'Epidemiology'</a>)</p><p></p><p class="bulletIndent1">Enterovirus (see  <a class="medical medical_review" href="/z/d/html/2694.html" rel="external">"Enterovirus and parechovirus infections: Epidemiology and pathogenesis", section on 'Transmission'</a>)</p><p></p><p class="bulletIndent1">Adenovirus (see  <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection", section on 'Transmission'</a>)</p><p></p><p class="bulletIndent1">Parainfluenza viruses (see  <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">"Parainfluenza viruses in children", section on 'Transmission and incubation period'</a>)</p><p></p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H7"><span class="h2">Clinical course</span><span class="headingEndMark"> — </span>The clinical course of roseola is characteristic: three to five days of fever that resolves abruptly and is followed by development of a rash.</p><p class="headingAnchor" id="H8"><span class="h3">Febrile phase</span><span class="headingEndMark"> — </span>Classical roseola begins with a fever that may exceed 40°C (104°F) and lasts for three to five days (mean 3.8 days) [<a href="#rid5">5-7,17,18</a>]. The fever often is accompanied by irritability, although most children with roseola are otherwise well-appearing, active, and alert [<a href="#rid1">1,5,7</a>].</p><p>A number of other clinical manifestations during the febrile phase of illness have been described in children with roseola [<a href="#rid1">1,6,18-21</a>]. In two case series of children with primary HHV-6 infection and rash or roseola, other clinical manifestations included palpebral conjunctivitis (25 percent), edematous eyelids (30 percent), acute otitis media/inflamed tympanic membrane (8 percent), uvulopalatoglossal junctional macules or ulcers (sometimes called Nagayama spots, 65 percent), rhinorrhea (61 percent), cough (62 percent) vomiting (21 percent), diarrhea (24 to 68 percent), and a bulging fontanelle (26 percent) [<a href="#rid6">6,21</a>]. Less common clinical manifestations include hepatitis, thrombocytopenia, mononucleosis-like syndrome, colitis, or myocarditis [<a href="#rid22">22-24</a>]. The combination of high fever and bulging fontanelle frequently results in an evaluation for possible meningitis.</p><p>Cervical, postauricular, and/or occipital lymphadenopathy are common, typically occurring two to four days after the onset of fever [<a href="#rid6">6</a>]. In two case series of patients with primary HHV-6 infection and rash and/or roseola, approximately one-third of patients had cervical lymphadenopathy [<a href="#rid6">6,21</a>].</p><p class="headingAnchor" id="H9"><span class="h3">Rash</span><span class="headingEndMark"> — </span>As the child's fever abates, a blanching macular or maculopapular rash develops, starting on the neck and trunk and spreading to the face and extremities (<a class="graphic graphic_picture graphicRef81967" href="/z/d/graphic/81967.html" rel="external">picture 1</a>). Occasionally the rash is vesicular. It is generally nonpruritic [<a href="#rid18">18</a>]. The rash typically persists for one to two days but occasionally may come and go within two to four hours [<a href="#rid1">1,5,25</a>]. In children receiving antibiotics, the later onset of the rash frequently is misinterpreted as a drug allergy. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>The pathogenesis of the rash is unclear [<a href="#rid1">1</a>]. It develops after the viremic phase of illness, coincident with the development of antibody to HHV-6, suggesting that it may result from antigen-antibody complexes [<a href="#rid2">2,26</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Laboratory features</span><span class="headingEndMark"> — </span>Laboratory investigation is seldom necessary for patients with classic roseola. However, it may be undertaken in children with atypical features (eg, simultaneous fever and rash) or as part of the evaluation of fever. (See  <a class="medical medical_review" href="/z/d/html/6075.html" rel="external">"Fever without a source in children 3 to 36 months of age: Evaluation and management"</a>.)</p><p>Laboratory features of roseola may include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neutropenia and atypical lymphocytosis</strong> – Children with roseola may have relative neutropenia and mild atypical lymphocytosis [<a href="#rid1">1,5,27-29</a>]. Early in the febrile period, the white blood cell count may be elevated but reaches its nadir (frequently in the range of 3000 cells/microL) by day 3 to 6 of illness, then gradually returns to normal over the following 7 to 10 days.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thrombocytopenia</strong> – Children with roseola also may have thrombocytopenia, which is thought to be caused by bone marrow suppression rather than immune-mediated peripheral consumption [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sterile pyuria</strong> – Children with roseola may have sterile pyuria. In a retrospective study from a single institution, 13 percent of 158 children with roseola had sterile pyuria [<a href="#rid20">20</a>]. During the febrile phase, urinary tract infection (UTI) may be a diagnostic consideration in children with pyuria. The differentiation of roseola from UTI is discussed below. (See <a class="local">'Fever and pyuria'</a> below.)</p><p></p><p class="headingAnchor" id="H11"><span class="h2">Complications</span><span class="headingEndMark"> — </span>Roseola is usually a benign, self-limited illness. Complications may include seizures, aseptic meningitis, encephalitis, and thrombocytopenic purpura. Seizures generally are related to fever. Febrile seizures occur in approximately 10 to 15 percent of children with primary HHV-6B infection [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/z/d/html/5969.html" rel="external">"Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Roseola is diagnosed clinically based on the characteristic features: fever for three to five days followed by abrupt defervescence and development of a rash in a young child [<a href="#rid1">1,3</a>].</p><p>Laboratory evaluation is seldom necessary. In most patients with roseola caused by human herpesvirus 6 (HHV-6), by the time the rash appears, viremia has resolved [<a href="#rid2">2,26</a>]. (See <a class="local">'Rash'</a> above.)</p><p>Virologic studies may be warranted in immunocompromised patients and those with an atypical presentation or complications. The diagnostic approach for potential pathogens is discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>HHV-6 (see  <a class="medical medical_review" href="/z/d/html/5969.html" rel="external">"Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HHV-7 (see  <a class="medical medical_review" href="/z/d/html/8309.html" rel="external">"Human herpesvirus 7 infection", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enterovirus (see  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Laboratory diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adenovirus (see  <a class="medical medical_review" href="/z/d/html/8348.html" rel="external">"Diagnosis, treatment, and prevention of adenovirus infection"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Parainfluenza virus type 1 (see  <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">"Parainfluenza viruses in children", section on 'Diagnosis'</a>)</p><p></p><p class="headingAnchor" id="H13"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of the roseola rash includes several other infectious exanthems and drug allergy (<a class="graphic graphic_figure graphicRef104587" href="/z/d/graphic/104587.html" rel="external">figure 1</a>) [<a href="#rid5">5</a>]. Roseola generally can be distinguished from these conditions by epidemiologic or clinical features (eg, age group, temporal relation between fever and rash). Roseola also must be distinguished from urinary tract infection (UTI) in children who present with fever before the onset of rash and are found to have pyuria during the evaluation of fever.</p><p>Establishing the correct diagnosis as roseola can alleviate caregiver concerns and limit unnecessary evaluations and antibiotic therapy [<a href="#rid30">30,31</a>].</p><p class="headingAnchor" id="H27443815"><span class="h2">Infectious exanthems</span><span class="headingEndMark"> — </span>The infectious exanthems to be considered in the differential diagnosis of roseola include (<a class="graphic graphic_figure graphicRef104587" href="/z/d/graphic/104587.html" rel="external">figure 1</a>) [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Rubella (<a class="graphic graphic_picture graphicRef61263" href="/z/d/graphic/61263.html" rel="external">picture 2</a>) is characterized by simultaneous occurrence of low-grade fever and rash. The rash classically begins on the face and spreads down the body. Rubella occurs in children who are unimmunized or underimmunized. (See  <a class="medical medical_review" href="/z/d/html/8301.html" rel="external">"Rubella"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rubeola (measles) (<a class="graphic graphic_picture graphicRef57093" href="/z/d/graphic/57093.html" rel="external">picture 3</a>), which is distinguished by a prodrome of fever followed by coryza, cough, and Koplik spots (<a class="graphic graphic_picture graphicRef57571" href="/z/d/graphic/57571.html" rel="external">picture 4</a>). The rash classically begins on the face and spreads down the body; it begins as small lesions that enlarge and coalesce. Rubeola occurs in children who are unimmunized or underimmunized. (See  <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enteroviral infections, which usually occur in epidemics in the spring, summer, and fall (typically with a peak in mid- to late summer) and occur in children of all ages, not just young children. Hand, foot, and mouth disease (HFMD) is the classic enteroviral rash (<a class="graphic graphic_picture graphicRef53423" href="/z/d/graphic/53423.html" rel="external">picture 5</a>). The oral enanthem (<a class="graphic graphic_picture graphicRef71314 graphicRef58566" href="/z/d/graphic/71314.html" rel="external">picture 6A-B</a>) is a characteristic feature of HFMD; prodromal symptoms usually are absent but may include low-grade fever. (See  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Laboratory diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/96219.html" rel="external">"Hand, foot, and mouth disease and herpangina"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Erythema infectiosum is characterized by a rash that is prominent on the cheeks (<a class="graphic graphic_picture graphicRef71737 graphicRef89522" href="/z/d/graphic/71737.html" rel="external">picture 7A-B</a>). The facial rash may be followed by a "lacelike" rash (reticulated blanching erythema) on the trunk and extremities (<a class="graphic graphic_picture graphicRef122702" href="/z/d/graphic/122702.html" rel="external">picture 8</a>), which may recur. Erythema infectiosum usually affects school-age children. Most children with erythema infectiosum have minimal or no symptoms; however, they may have a nonspecific prodrome (eg, fever, coryza, headache, nausea, diarrhea). (See  <a class="medical medical_review" href="/z/d/html/8272.html" rel="external">"Clinical manifestations and diagnosis of parvovirus B19 infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Scarlet fever is characterized by a rash that is diffuse, erythematous, and sandpaper-like (<a class="graphic graphic_picture graphicRef63234" href="/z/d/graphic/63234.html" rel="external">picture 9</a>). The rash occurs with or is preceded by pharyngitis. Children with scarlet fever may develop confluent petechiae in the antecubital fossae (Pastia lines). Resolution of the rash is followed by desquamation and/or frank peeling. (See  <a class="medical medical_review" href="/z/d/html/8046.html" rel="external">"Complications of streptococcal tonsillopharyngitis", section on 'Scarlet fever'</a>.)</p><p></p><p class="headingAnchor" id="H27443821"><span class="h2">Drug allergy</span><span class="headingEndMark"> — </span>Drug allergy is an important consideration in children with fever who are treated with antibiotics and then develop a rash (<a class="graphic graphic_picture graphicRef70062" href="/z/d/graphic/70062.html" rel="external">picture 10</a>). Clinical features that help to distinguish drug allergy from roseola include the duration of rash (longer in drug allergy than in roseola), and pruritus (present in drug allergy, not in roseola) [<a href="#rid1">1,18</a>]. (See  <a class="medical medical_review" href="/z/d/html/2073.html" rel="external">"Penicillin allergy: Immediate reactions"</a>.)</p><p class="headingAnchor" id="H87386541"><span class="h2">Fever and pyuria</span><span class="headingEndMark"> — </span>UTI is a consideration among infants who present with fever before the onset of the characteristic roseola rash and are found to have pyuria during the evaluation of fever. (See <a class="local">'Laboratory features'</a> above.)</p><p>Urine culture results will ultimately differentiate UTI from roseola in such children. A retrospective study of 158 young children (one month to three years) with roseola and 143 young children with UTI identified presenting clinical and laboratory findings more suggestive of UTI than roseola [<a href="#rid20">20</a>]. Peripheral white blood cell (WBC) count &gt;10,000 cells/microL was the most helpful single finding (occurring in 70 percent of children with UTI and only 4 percent of those with roseola). Additional findings that were more common among children with UTI than roseola included male sex, age &lt;6 months, C-reactive protein &gt;0.5 mg/dL (5 mg/L), and fever of &lt;4 days duration at presentation. Although not examined in the study, a positive nitrite test by dipstick analysis is highly suggestive of UTI. (See  <a class="medical medical_review" href="/z/d/html/5990.html" rel="external">"Urinary tract infections in infants and children older than one month: Clinical features and diagnosis", section on 'Rapidly available tests'</a>.)</p><p>Pending urine culture results, decisions regarding empiric antibiotics are best made on a case-by-case basis based upon the probability of UTI, which is determined by demographic and clinical factors (eg, age, circumcision status, urinary tract anomalies, etc) [<a href="#rid32">32</a>]. To prevent unnecessary use of antibiotics in children in whom both UTI and roseola are being considered, it may be reasonable to withhold antibiotics pending urine culture results among those who are well-appearing, ≥6 months of age, have peripheral WBC count between 5000 and 10,000 cells/microL, and negative nitrites on dipstick analysis. (See  <a class="medical medical_review" href="/z/d/html/5991.html" rel="external">"Urinary tract infections in infants older than one month and children less than two years: Acute management, imaging, and prognosis", section on 'Determining need for early empiric antibiotic therapy'</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>In most cases, roseola is a benign and self-limited disease. Treatment is supportive [<a href="#rid3">3</a>]. Fever can be controlled with antipyretics (eg, <a class="drug drug_pediatric" data-topicid="13028" href="/z/d/drug information/13028.html" rel="external">acetaminophen</a>) if it is associated with discomfort. The rash resolves without treatment. (See  <a class="medical medical_review" href="/z/d/html/5989.html" rel="external">"Fever in infants and children: Pathophysiology and management", section on 'Management of fever'</a>.)</p><p>Associated clinical features should be treated as indicated (eg, ensuring adequate fluid intake for infants with diarrhea or vomiting).</p><p class="headingAnchor" id="H15"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Most children with roseola recover spontaneously without sequelae.</p><p class="headingAnchor" id="H16"><span class="h1">PREVENTION</span></p><p class="headingAnchor" id="H17"><span class="h2">Hygiene</span><span class="headingEndMark"> — </span>Roseola may be caused by several viruses. Transmission of human herpesvirus 6, the most common cause, probably results from asymptomatic shedding of virus in secretions of close contacts, which is difficult to prevent [<a href="#rid15">15</a>]. The other viruses that cause roseola typically are spread through respiratory secretions or the fecal-oral route. Simple hygienic measures, such as handwashing, may help to prevent spread. (See  <a class="medical medical_review" href="/z/d/html/2694.html" rel="external">"Enterovirus and parechovirus infections: Epidemiology and pathogenesis"</a> and  <a class="medical medical_review" href="/z/d/html/8348.html" rel="external">"Diagnosis, treatment, and prevention of adenovirus infection", section on 'Prevention'</a>.)</p><p class="headingAnchor" id="H18"><span class="h2">Child care</span><span class="headingEndMark"> — </span>There is no recommended period of exclusion from out-of-home child care for children with roseola [<a href="#rid33">33</a>]. Children with sporadic cases of roseola are not considered to be contagious [<a href="#rid1">1,5</a>].</p><p class="headingAnchor" id="H6398197"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/17204.html" rel="external">"Patient education: Roseola (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology and epidemiology</strong> – Human herpesvirus 6 (HHV-6) is the most frequent cause of roseola. Other causes include HHV-7, enteroviruses, adenovirus, and parainfluenza virus type 1. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1">Roseola is an illness of young children, with a peak prevalence between 7 and 13 months. It occurs throughout the year. Most cases occur sporadically without known exposure. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical and laboratory features </strong>– Roseola classically begins with three to five days of fever that may exceed 40°C (104°F); as the fever abates, a blanching macular or maculopapular rash develops, starting on the neck and trunk and spreading to the face and extremities (<a class="graphic graphic_picture graphicRef81967" href="/z/d/graphic/81967.html" rel="external">picture 1</a>). (See <a class="local">'Clinical course'</a> above.)</p><p></p><p class="bulletIndent1">Laboratory investigation is seldom necessary for patients with classic roseola. However, it may be undertaken in children with atypical features or as part of the evaluation of fever. Laboratory features of roseola include relative neutropenia and mild atypical lymphocytosis. Children with roseola also may have thrombocytopenia or sterile pyuria. (See <a class="local">'Laboratory features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis and differential diagnosis</strong> – Roseola is diagnosed clinically based on the characteristic features: fever for three to five days followed by abrupt defervescence and development of a rash in a young child (<a class="graphic graphic_picture graphicRef81967" href="/z/d/graphic/81967.html" rel="external">picture 1</a>). (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">The differential diagnosis of roseola includes several other infectious exanthems and drug allergy (<a class="graphic graphic_figure graphicRef104587" href="/z/d/graphic/104587.html" rel="external">figure 1</a>). (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management and prevention</strong> – Roseola is usually a benign self-limited disease. Treatment is supportive (eg, control of fever if it is associated with discomfort). (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1">Standard hygienic measures, such as handwashing, may help to prevent spread of the viral pathogens that cause roseola. There is no recommended period of exclusion from out-of-home child care for children with roseola. (See <a class="local">'Prevention'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Cherry JD. Roseola infantum (exanthem subitum). In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.559.</li><li><a class="nounderline abstract_t">Asano Y, Yoshikawa T, Suga S, et al. Viremia and neutralizing antibody response in infants with exanthem subitum. J Pediatr 1989; 114:535.</a></li><li class="breakAll">Jenista JA. Human herpesvirus-6 and human herpesvirus-7 infections. In: Textbook of Pediatric Care, McInerny TK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009.</li><li><a class="nounderline abstract_t">Tanaka K, Kondo T, Torigoe S, et al. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr 1994; 125:1.</a></li><li><a class="nounderline abstract_t">JURETIC M. Exanthema subitum a review of 243 cases. Helv Paediatr Acta 1963; 18:80.</a></li><li><a class="nounderline abstract_t">Asano Y, Yoshikawa T, Suga S, et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 1994; 93:104.</a></li><li><a class="nounderline abstract_t">Meade RH 3rd. Exanthem subitum (roseola infantum). Clin Dermatol 1989; 7:92.</a></li><li><a class="nounderline abstract_t">Breese BB. Roseola infantum (exanthem subitum). N Y State J Med 1941; 41:1854.</a></li><li><a class="nounderline abstract_t">Barenberg LH, Greenspan L. Exanthema subitum (roseola infantum). Am J Dis Child 1939; 58:983.</a></li><li><a class="nounderline abstract_t">Iio K, Matsubara K, Miyakoshi C, et al. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ Paediatr Open 2021; 5:e001034.</a></li><li><a class="nounderline abstract_t">Hibiya K, Iwata H, Kinjo T, et al. Incidence of common infectious diseases in Japan during the COVID-19 pandemic. PLoS One 2022; 17:e0261332.</a></li><li><a class="nounderline abstract_t">Tachikawa J, Aizawa Y, Ikuse T, et al. Changes in Exanthema Subitum Incidence and Patient Age Distribution During the COVID-19 Pandemic in Japan. Pediatr Infect Dis J 2022; 41:e90.</a></li><li><a class="nounderline abstract_t">Aktürk H, Bağci MS, Yiğit MH, et al. Roseola Infantum During the COVID-19 Pandemic. J Pediatr Hematol Oncol 2022; 44:e296.</a></li><li><a class="nounderline abstract_t">Miyazaki Y, Namba H, Torigoe S, et al. Monitoring of human herpesviruses-6 and -7 DNA in saliva samples during the acute and convalescent phases of exanthem subitum. J Med Virol 2017; 89:696.</a></li><li class="breakAll">American Academy of Pediatrics. Human herpesvirus 6 (including roseola) and 7. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.422.</li><li><a class="nounderline abstract_t">Harnett GB, Farr TJ, Pietroboni GR, Bucens MR. Frequent shedding of human herpesvirus 6 in saliva. J Med Virol 1990; 30:128.</a></li><li><a class="nounderline abstract_t">Stoeckle MY. The spectrum of human herpesvirus 6 infection: from roseola infantum to adult disease. Annu Rev Med 2000; 51:423.</a></li><li><a class="nounderline abstract_t">Clemens HH. Exanthem subitum (roseola infantum): report of 80 cases. J Pediatr 1945; 26:66.</a></li><li><a class="nounderline abstract_t">BERLINER BC. A physical sign useful in diagnosis of roseola infantum before the rash. Pediatrics 1960; 25:1034.</a></li><li><a class="nounderline abstract_t">Huang CT, Lin LH. Differentiating roseola infantum with pyuria from urinary tract infection. Pediatr Int 2013; 55:214.</a></li><li><a class="nounderline abstract_t">Vianna RA, de Oliveira SA, Camacho LA, et al. Role of human herpesvirus 6 infection in young Brazilian children with rash illnesses. Pediatr Infect Dis J 2008; 27:533.</a></li><li><a class="nounderline abstract_t">De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005; 18:217.</a></li><li><a class="nounderline abstract_t">Zerr DM. Human herpesvirus 6: a clinical update. Herpes 2006; 13:20.</a></li><li class="breakAll">Descamps V, Tohama M, Kano Y, Shiohava T. HHV-6A and HHV-6B in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. In: Human Herpesviruses HHV-6A, HHV-6B, and HHV-7: Diagnosis and Clinical Management, 3rd ed, Flamand L, Lautenschlager I, Krueger GRF, Ablashi DV (Eds), Elsevier, Amsterdam 2014. p.179.</li><li><a class="nounderline abstract_t">BERENBERG W, WRIGHT S, JANEWAY CA. Roseola infantum (exanthem subitum). N Engl J Med 1949; 241:253.</a></li><li><a class="nounderline abstract_t">Hall CB. Herpes and the rash of roses: a new virus, HHV-6, as a cause of an old childhood disease, roseola. Pediatr Ann 1990; 19:517.</a></li><li><a class="nounderline abstract_t">Caserta MT, Hall CB, Schnabel K, et al. Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr 1998; 133:386.</a></li><li><a class="nounderline abstract_t">LETCHNER A. Roseola infantum; a review of fifty cases. Lancet 1955; 269:1163.</a></li><li><a class="nounderline abstract_t">Hashimoto H, Maruyama H, Fujimoto K, et al. Hematologic findings associated with thrombocytopenia during the acute phase of exanthem subitum confirmed by primary human herpesvirus-6 infection. J Pediatr Hematol Oncol 2002; 24:211.</a></li><li><a class="nounderline abstract_t">Leung AKC, Lam J, Barankin B, et al. Roseola Infantum: An Updated Review. Curr Pediatr Rev 2022.</a></li><li><a class="nounderline abstract_t">Wiersbitzky S, Eberle J, Ladstätter L, et al. [The critical 3-day fever-exanthema in young children (exanthema subitum, Zahorsky roseola infantum)--what is new?]. Padiatr Grenzgeb 1989; 28:351.</a></li><li><a class="nounderline abstract_t">Shaikh N, Morone NE, Lopez J, et al. Does this child have a urinary tract infection? JAMA 2007; 298:2895.</a></li><li><a class="nounderline abstract_t">Richardson M, Elliman D, Maguire H, et al. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 2001; 20:380.</a></li></ol></div><div id="topicVersionRevision">Topic 6035 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cherry JD. Roseola infantum (exanthem subitum). In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.559.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2647944" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Viremia and neutralizing antibody response in infants with exanthem subitum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2647944" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Viremia and neutralizing antibody response in infants with exanthem subitum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8021757" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Human herpesvirus 7: another causal agent for roseola (exanthem subitum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13958107" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Exanthema subitum a review of 243 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8265302" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2647267" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Exanthem subitum (roseola infantum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Roseola infantum (exanthem subitum)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Exanthema subitum (roseola infantum)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33884312" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35020724" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Incidence of common infectious diseases in Japan during the COVID-19 pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35144267" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Changes in Exanthema Subitum Incidence and Patient Age Distribution During the COVID-19 Pandemic in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33828033" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Roseola Infantum During the COVID-19 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27648817" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Monitoring of human herpesviruses-6 and -7 DNA in saliva samples during the acute and convalescent phases of exanthem subitum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27648817" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Monitoring of human herpesviruses-6 and -7 DNA in saliva samples during the acute and convalescent phases of exanthem subitum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2156005" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Frequent shedding of human herpesvirus 6 in saliva.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10774474" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The spectrum of human herpesvirus 6 infection: from roseola infantum to adult disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Exanthem subitum (roseola infantum): report of 80 cases</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13799552" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A physical sign useful in diagnosis of roseola infantum before the rash.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23190314" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Differentiating roseola infantum with pyuria from urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18449066" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Role of human herpesvirus 6 infection in young Brazilian children with rash illnesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15653828" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Update on human herpesvirus 6 biology, clinical features, and therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16732999" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Human herpesvirus 6: a clinical update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16732999" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Human herpesvirus 6: a clinical update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18138680" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Roseola infantum (exanthem subitum).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2172897" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Herpes and the rash of roses: a new virus, HHV-6, as a cause of an old childhood disease, roseola.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9738722" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13272349" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Roseola infantum; a review of fifty cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11990308" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hematologic findings associated with thrombocytopenia during the acute phase of exanthem subitum confirmed by primary human herpesvirus-6 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36411550" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Roseola Infantum: An Updated Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2560825" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : [The critical 3-day fever-exanthema in young children (exanthema subitum, Zahorsky roseola infantum)--what is new?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18159059" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Does this child have a urinary tract infection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11332662" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
